Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junfeng Shi

Showing results (191-200 of 244) with videos related to

Pageof 25
Sort By:
BMC Cancer|April 23, 2024
Systematic optimization and evaluation of culture conditions for the construction of circulating tumor cell clusters using breast cancer cell linesJueyao Zou, Qiong Chen, Yong He, et al.
Journal of Oncology|February 14, 2022
Tegaserod Maleate Inhibits Breast Cancer Progression and Enhances the Sensitivity of ImmunotherapyXiao Li, Liangliang Wu, Zhiying Zheng, et al.
Genes & Diseases|August 17, 2023
A novel FGFR1 inhibitor CYY292 suppresses tumor progression, invasion, and metastasis of glioblastoma by inhibiting the Akt/GSK3β/snail signaling axisYanran Bi, Ruiling Zheng, Jiahao Hu, et al.
Acta Biochimica Et Biophysica Sinica|February 4, 2026
Multifaceted elucidation of aminoguanidine in protecting against diabetes-induced vascular endothelial injuryHuiru Tang, Yuhan Zhai, Gaojun Wang, et al.
Biochemical and Biophysical Research Communications|August 7, 2023
Secreted frizzled-related protein 5: A promising therapeutic target for metabolic diseases via regulation of Wnt signalingYixin Song, Yujie Ma, Kexin Zhang, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|February 6, 2026
12,13-diHOME ameliorates MASLD by regulating Sestrin2-mediated AMPK/ULK1/Lipophagy in obese miceKexin Zhang, Chengxia Kan, Hongyan Qiu, et al.
Genes & Diseases|January 31, 2024
Corrigendum to "A novel FGFR1 inhibitor CYY292 suppresses tumor progression, invasion, and metastasis of glioblastoma by inhibiting the Akt/GSK3β/snail signaling axis" [Genes & Diseases 11 (2024) 479-494]Yanran Bi, Ruiling Zheng, Jiahao Hu, et al.
Advanced Healthcare Materials|February 25, 2017
Selectively Inducing Cancer Cell Death by Intracellular Enzyme-Instructed Self-Assembly (EISA) of Dipeptide DerivativesJie Li, Junfeng Shi, Jamie E Medina, et al.
International Immunopharmacology|February 21, 2024
Edaravone dexborneol alleviates ischemic injury and neuroinflammation by modulating microglial and astrocyte polarization while inhibiting leukocyte infiltrationDongxue Wang, Yutao Wang, Junfeng Shi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 17, 2023
From Immunogen to COVID-19 vaccines: Prospects for the post-pandemic eraGanggang Miao, Zhiqiang Chen, Hengsong Cao, et al.
Pageof 25

Showing results (191-200 of 244) with videos related to

Sort By:
Pageof 25
BMC Cancer|April 23, 2024
Systematic optimization and evaluation of culture conditions for the construction of circulating tumor cell clusters using breast cancer cell linesJueyao Zou, Qiong Chen, Yong He, et al.
Journal of Oncology|February 14, 2022
Tegaserod Maleate Inhibits Breast Cancer Progression and Enhances the Sensitivity of ImmunotherapyXiao Li, Liangliang Wu, Zhiying Zheng, et al.
Genes & Diseases|August 17, 2023
A novel FGFR1 inhibitor CYY292 suppresses tumor progression, invasion, and metastasis of glioblastoma by inhibiting the Akt/GSK3β/snail signaling axisYanran Bi, Ruiling Zheng, Jiahao Hu, et al.
Acta Biochimica Et Biophysica Sinica|February 4, 2026
Multifaceted elucidation of aminoguanidine in protecting against diabetes-induced vascular endothelial injuryHuiru Tang, Yuhan Zhai, Gaojun Wang, et al.
Biochemical and Biophysical Research Communications|August 7, 2023
Secreted frizzled-related protein 5: A promising therapeutic target for metabolic diseases via regulation of Wnt signalingYixin Song, Yujie Ma, Kexin Zhang, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|February 6, 2026
12,13-diHOME ameliorates MASLD by regulating Sestrin2-mediated AMPK/ULK1/Lipophagy in obese miceKexin Zhang, Chengxia Kan, Hongyan Qiu, et al.
Genes & Diseases|January 31, 2024
Corrigendum to "A novel FGFR1 inhibitor CYY292 suppresses tumor progression, invasion, and metastasis of glioblastoma by inhibiting the Akt/GSK3β/snail signaling axis" [Genes & Diseases 11 (2024) 479-494]Yanran Bi, Ruiling Zheng, Jiahao Hu, et al.
Advanced Healthcare Materials|February 25, 2017
Selectively Inducing Cancer Cell Death by Intracellular Enzyme-Instructed Self-Assembly (EISA) of Dipeptide DerivativesJie Li, Junfeng Shi, Jamie E Medina, et al.
International Immunopharmacology|February 21, 2024
Edaravone dexborneol alleviates ischemic injury and neuroinflammation by modulating microglial and astrocyte polarization while inhibiting leukocyte infiltrationDongxue Wang, Yutao Wang, Junfeng Shi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 17, 2023
From Immunogen to COVID-19 vaccines: Prospects for the post-pandemic eraGanggang Miao, Zhiqiang Chen, Hengsong Cao, et al.
Pageof 25